Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination by Albertson, Timothy E., Hansen, Caitlin, Bihari, Smiti, Gayed, Juleen, Xu, Xia, Simón-Campos, J. Abraham, Dever, Michael E., Cardona, Jose F., Mitha, Essack, Baker, Jeffrey B., Keep, Georgina, Oladipupo, Islamiat, Mensa, Federico J., Feng, Ye, Ma, Hua, Koury, Kenneth, Mather, Susan, Ianos, Claudia Ana, Anderson, Annaliesa S., Türeci, Özlem, Şahin, Uǧur, Gruber, William C., Gurtman, Alejandra, Sabharwal, Charu, Kitchin, Nicholas

Get full text

Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine by Moreira, Edson D, Kitchin, Nicholas, Xu, Xia, Dychter, Samuel S, Lockhart, Stephen, Gurtman, Alejandra, Perez, John L, Zerbini, Cristiano, Dever, Michael E, Jennings, Timothy W, Brandon, Donald M, Cannon, Kevin D, Koren, Michael J, Denham, Douglas S, Berhe, Mezgebe, Fitz-Patrick, David, Hammitt, Laura L, Klein, Nicola P, Haylene Nell, Keep, Georgina, Wang, Xingbin, Koury, Kenneth, Swanson, Kena A, Cooper, David, Lu, Claire, Türeci, Özlem, Lagkadinou, Eleni, Tresnan, Dina B, Dormitzer, Philip R, Şahin, Uğur, Gruber, William C, Jansen, Kathrin U

Request full text